Not applicableEnded earlyNCT01872377
What this trial is testing
Dose Escalation Study of CyberKnife® SBRT Boost for Patients With Unresectable Locally Advanced Pancreatic Cancer
Who this might be right for
Pancreatic Carcinoma Non-resectable
Ottawa Hospital Research Institute 7